Start for free
Start for free
Start Codon logo

Start Codon

Europe, Cambridgeshire, United Kingdom, Cambridge

Description

Translating disruptive research into successful start-ups, the Cambridge way

Investor Profile

Start Codon has made 7 investments, with 2 in the past 12 months and 29% as lead.

Stage Focus

  • Seed (86%)
  • Pre Seed (14%)

Country Focus

  • United Kingdom (86%)
  • United States (14%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Life Science
  • Health Care
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Oncology
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Start Codon frequently co-invest with?

The Venture Collective
The Venture Collective
North America, New York, United States, New York
Co-Investments: 1
Divergent Capital
Divergent Capital
North America, New York, United States, New York
Co-Investments: 1
Bioqube Ventures
Bioqube Ventures
Europe, Limburg, Belgium, Hasselt
Co-Investments: 1
TI
the Imperial College Innovation Fund
Europe, England, United Kingdom, London
Co-Investments: 1
UK Innovation & Science Seed Fund
UK Innovation & Science Seed Fund
Europe, Oxfordshire, United Kingdom, Harwell
Co-Investments: 1
Cancer Research Horizons
Cancer Research Horizons
Europe, England, United Kingdom, London
Co-Investments: 1
Development Bank of Wales
Development Bank of Wales
Europe, Cardiff, United Kingdom, Cardiff
Co-Investments: 1
Future Planet Capital
Future Planet Capital
Europe, England, United Kingdom, London
Co-Investments: 1
MA
Meltwind Advisory
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 2
2048 Ventures
2048 Ventures
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Start Codon?

TRIMTECH Therapeutics

Cambridge, Massachusetts, United States

TRIMTECH Therapeutics treats inflammatory and persistent CNS conditions by focusing on the elimination of harmful proteins.

BiotechnologyMedicalTherapeutics
SeedMar 5, 2025
Amount Raised: $31,000,000
Awen Oncology

Wales, Cumbria, United Kingdom

Awen Oncology is a pharmaceuticals start-up that is drugging developmentally-silent oncogenic drivers.

OncologyPharmaceutical
SeedAug 22, 2024
NK:IO

London, England, United Kingdom

NK:IO is a biotech company that develops novel approaches to natural killer cell-mediated immunotherapy.

BiotechnologyLife ScienceTherapeutics
SeedJul 25, 2023
Amount Raised: $1,547,243
coding.bio

Oxford, Oxfordshire, United Kingdom

ML-Based Design of CAR-T Cell Therapies

Artificial Intelligence (AI)BiotechnologyLife ScienceTherapeutics
SeedOct 26, 2022
Enhanc3D Genomics

Cambridge, Cambridgeshire, United Kingdom

Enhanc3D Genomics is a functional genomics company exploring the 3D organization of DNA in health and disease.

Biotechnology
SeedJan 1, 2021
Spirea

Cambridge, Cambridgeshire, United Kingdom

Spirea Ltd. operates as a healthcare technology company.

BiotechnologyHealth CarePharmaceutical
SeedJul 13, 2020
Semarion

Cambridge, Cambridgeshire, United Kingdom

Semarion leverages microfabrication technology to build smart materials and develop novel cell assaying applications.

BiotechnologyHealth CareTherapeutics
Pre SeedJun 22, 2020
Amount Raised: $312,515
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator